AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 62 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $852,000 | -16.8% | 130,000 | -17.5% | 0.01% | -15.4% |
| Q1 2019 | $1,024,000 | -4.7% | 157,500 | 0.0% | 0.01% | -23.5% |
| Q4 2018 | $1,074,000 | +2.7% | 157,500 | 0.0% | 0.02% | +21.4% |
| Q3 2018 | $1,046,000 | +17.9% | 157,500 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $887,000 | +44.9% | 157,500 | +33.5% | 0.01% | +40.0% |
| Q1 2018 | $612,000 | +14.4% | 118,000 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $535,000 | -27.7% | 118,000 | 0.0% | 0.01% | -30.8% |
| Q3 2017 | $740,000 | +2.4% | 118,000 | 0.0% | 0.01% | -7.1% |
| Q2 2017 | $723,000 | -16.5% | 118,000 | 0.0% | 0.01% | -17.6% |
| Q1 2017 | $866,000 | – | 118,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |